Auto_MA_T_Ka Posted - 2 hours ago

CRISPR Therapeutics $CRSP this week closed above its best respected 5-week SMA resistance line for the first time since it was first broken in March. $VRTX $NTLA $EDIT $BEAM -- 📉Find the BEST Respected Moving Average Support & Resistance Lines📈

ElijahJobs Posted - 8 hours ago

$VRTX Well on the way to $600 next year!

svertical1 Posted - 8 hours ago

$CRSP $EDIT $VRTX $NTLA $TNYA Which companies are best positioned for this pace of discovery? CRSP, NTLA, EDIT, BEAM, TNYA https://youtu.be/W4_xG9sxX7A?si=VCY4z8Rmaln2u9l6 Big question, can FDA keep up?

svertical1 Posted - 8 hours ago

$TNYA $VRTX Vertex should partner to enter cardio market with deal similar to CRSP’s CASGEVY. $1 Billion and develop to approval- share revenue after approval.

sanjay71 Posted - 12 hours ago

$VRTX another scam company selling fake science of genomics. If genes can be changed does that not make paternity and forensics gene tests invalid? Junk science of genetics used to make $$$.

svertical1 Posted - 1 day ago

$VRTX The move to $500-$600 will likely occur pre-Pain/VX-548 Approval. Stealth move so far, ready for volume to kick in above $445. Given trial results, VX-548 FDA Approval inevitable, just timing now.

kagrawala Posted - 1 day ago

$VRTX nice consolidation and move up. 500 very realistic in 12 months. Long VRTX

Rubiks_KubeMD Posted - 1 day ago

$VRTX beauty

Mergerbrief Posted - 1 day ago

$ALPN $VRTX - Tender Offer Expires MergerBrief.com

Timefortendies77 Posted - 2 days ago

$VRTX Are we just moving on momentum and upgrades? Loving this move from 400 to 440. There are major catalysts coming but they are more towards end of year. PAIN HUGE! Would be nice if options market is more liquid and you didn't have to take a loss just to buy 1 option.

Whiskeyunderthebed Posted - 2 days ago

$VRTX this is a monster move the last week- I hope we can continue and hold.

analytics Posted - 3 days ago

$VRTX The competition in the CF market is heating up. In such a small space, having so many big boys as competitors is a risk factor that must be considered. Just because something in the past was leading, we can not assume that it won't be severely challenged by the space disruptors. Do your thorough DD on ABBV-3067, a CFTR potentiator, and ABBV-2222, a CFTR corrector, AZD1656 CFTR corrector, CFTR potentiator called BI 127731, Brexanolone (VX-147) that targets inflammation in CF, Roche CFTR corrector RO749513 ... Stay safe! Those are some formidable players in the space and ready to eat others' lunch at the drop of a pin! The mktCap and PE here does not leave any room for any weakness in any of the dimensions of the business!

Forest_dweller Posted - 3 days ago

$VRTX

svertical1 Posted - 3 days ago

$VRTX Trial data and results are great, but for non opioid Pain, what matters is ‘does it work’? Physicians/Surgeons/Dentists are quick to move from one pain med to another to find what works for a patient. No doubt, VX-548 will be in that equation. Then usage success builds upon itself!

svertical1 Posted - 3 days ago

$VRTX Nice breakout on one year chart

svertical1 Posted - 3 days ago

$VRTX Make no mistake, it’s a good Pain! VX-548

777Dog Posted - 4 days ago

$VRTX $BLUE $EDIT

777Dog Posted - 4 days ago

@CRSPRCAS They have the best in class here...why knock down BCL11a in erythroid cells and pay $EDIT when you can simply change the promoter and buy $EDIT. The Vertex SSD target inventor spent his life on transcription factors to come up with the Vertex trick...then a new tool came along...whoopsie... $VRTX has real competition beyond the HIV $BLUE and just wait for Thal (the huge global market)...then watch $EDIT go IN VIVO for Hematopoietic stem cells... Geez, I wonder why an insider bought today at $5.64 when she could have had Vertex at $430...you are sooooo overvalued...

TickerDD_com Posted - 4 days ago

From 4/26/2024, looking back across 22 Month-Ends for VRTX, Percentage Change of Average Monthly Price had More Positives (55%) while Percentage Change of Average Monthly Volume had All Positives (100%) $VRTX #VRTX #VRTXStock #TickerDD https://www.youtube.com/watch?v=yTtHvQGxHmg

Stocksrunner Posted - 4 days ago

$VRTX A compelling growth story in biotech? The cystic fibrosis drugmaker's innovative pipeline and strong cash flows could sustain its momentum, enticing growth investors in the volatile biotech sector. https://stocksrunner.com/symbol/VRTX

analytics Posted - 4 days ago

$VRTX Its showing pretty severe bearish divergence today, down (-6) bucks, despite the fact that the tube lady was pumping it earlier, isn't it?

Fullsend101 Posted - 4 days ago

$ENSC $VRTX

777Dog Posted - 4 days ago

$EDIT oh my…rapid 100% cured with no extra toxicity…. Goodbye $BLUE, move aside $VRTX / $CRSP…f*kin A…. https://library.ehaweb.org/eha/2024/eha2024-congress/422389/rabi.hanna.reni-cel.the.first.ascas12a.gene-edited.cell.therapy.led.to.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D2%2Asearch%3Ds285

ElijahJobs Posted - 5 days ago

$VRTX Wow!

svertical1 Posted - 5 days ago

$VRTX Ranked in order of potential Revenue and necessary Patient Outcome? •Pain •Weight Loss •Wrinkles Or acronym Pew!

svertical1 Posted - 5 days ago

$VRTX Funny, WS Analysts calculators don’t go high enough to estimate potential of VX-548. Just like they fail to understand the ‘pain’ caused to themselves and the markets by naked shorting. 8 Halts on GME today. Any halts on VRTX years ago when GILD ate their lunch on HepC?

svertical1 Posted - 5 days ago

$VRTX Approved: CF, SCD, TDT Near Approval: Pain, Kidney Trial Results Sooner than most think: T1D, DMD More CRSP CASGEVY type Partnerships! Rinse & Repeat!

CTFNLighthouse Posted - 5 days ago

$ALPN $VRTX The HSR waiting period in connection with Vertex Pharmaceuticals’ proposed acquisition of Alpine Immune Sciences expired on May 9. The tender offer will expire at one minute past 11:59pm ET on May 17, unless the offer is extended.

JFDI Posted - 5 days ago

$VRTX 500 in the cards

Monkey_Banana_Genius Posted - 5 days ago

$VRTX trimming 25% of my long